Estimating regimen‐specific costs of chemotherapy for breast cancer: Observational cohort study

One goal for high‐quality patient care is communicating treatment costs to patients, yet cost information can be elusive. This is especially relevant for breast cancer care, for which numerous guideline‐concordant adjuvant chemotherapy regimens exist. The objective of the current study was to generate cost estimates for such regimens from payers’ and patients’ perspectives in a large, insured US population.

[1]  P. Newcomb,et al.  Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Jemal,et al.  Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Adam P Dicker,et al.  American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  S. Nass,et al.  Ensuring Patient Access to Affordable Cancer Drugs: Workshop Summary , 2015 .

[5]  G. Hortobagyi,et al.  Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Sarah T. Hawley,et al.  Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Sharyl J. Nass,et al.  Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis , 2014 .

[8]  P. Newcomb,et al.  Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. , 2013, Health affairs.

[9]  A. Abernethy,et al.  The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. , 2013, The oncologist.

[10]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[11]  Eric J Feuer,et al.  Projections of the cost of cancer care in the United States: 2010-2020. , 2011, Journal of the National Cancer Institute.

[12]  E. Lamont,et al.  Evaluation of trends in the cost of initial cancer treatment. , 2008, Journal of the National Cancer Institute.

[13]  Purushottam W. Laud,et al.  An Algorithm for the Use of Medicare Claims Data to Identify Women with Incident Breast Cancer , 2004 .

[14]  Ruth Etzioni,et al.  Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare Data , 2002, Medical care.

[15]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[16]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.